Logo image of IX

ORIX - SPONSORED ADR (IX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:IX - US6863301015 - ADR

29.88 USD
-0.19 (-0.63%)
Last: 1/7/2026, 5:25:49 PM
29.88 USD
0 (0%)
After Hours: 1/7/2026, 5:25:49 PM
Fundamental Rating

4

Overall IX gets a fundamental rating of 4 out of 10. We evaluated IX against 98 industry peers in the Financial Services industry. IX has a medium profitability rating, but doesn't score so well on its financial health evaluation. IX has a valuation in line with the averages, but on the other hand it scores bad on growth. Finally IX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year IX was profitable.
In the past year IX had a positive cash flow from operations.
Each year in the past 5 years IX has been profitable.
IX had a positive operating cash flow in each of the past 5 years.
IX Yearly Net Income VS EBIT VS OCF VS FCFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B 1T

1.2 Ratios

With a decent Return On Assets value of 2.08%, IX is doing good in the industry, outperforming 63.27% of the companies in the same industry.
The Return On Equity of IX (8.60%) is comparable to the rest of the industry.
The Return On Invested Capital of IX (2.59%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for IX is significantly below the industry average of 8.44%.
Industry RankSector Rank
ROA 2.08%
ROE 8.6%
ROIC 2.59%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
IX Yearly ROA, ROE, ROICIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

IX's Profit Margin of 12.23% is in line compared to the rest of the industry. IX outperforms 57.14% of its industry peers.
In the last couple of years the Profit Margin of IX has declined.
The Operating Margin of IX (19.00%) is better than 66.33% of its industry peers.
In the last couple of years the Operating Margin of IX has remained more or less at the same level.
Looking at the Gross Margin, with a value of 42.41%, IX is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
IX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19%
PM (TTM) 12.23%
GM 42.41%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
IX Yearly Profit, Operating, Gross MarginsIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IX is destroying value.
The number of shares outstanding for IX has been reduced compared to 1 year ago.
Compared to 5 years ago, IX has less shares outstanding
IX has a better debt/assets ratio than last year.
IX Yearly Shares OutstandingIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IX Yearly Total Debt VS Total AssetsIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5T 10T 15T

2.2 Solvency

IX has an Altman-Z score of 0.79. This is a bad value and indicates that IX is not financially healthy and even has some risk of bankruptcy.
IX has a Altman-Z score (0.79) which is in line with its industry peers.
A Debt/Equity ratio of 1.54 is on the high side and indicates that IX has dependencies on debt financing.
The Debt to Equity ratio of IX (1.54) is worse than 61.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Altman-Z 0.79
ROIC/WACC0.7
WACC3.68%
IX Yearly LT Debt VS Equity VS FCFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T

2.3 Liquidity

IX has a Current Ratio of 0.94. This is a bad value and indicates that IX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of IX (0.94) is comparable to the rest of the industry.
IX has a Quick Ratio of 0.94. This is a bad value and indicates that IX is not financially healthy enough and could expect problems in meeting its short term obligations.
IX has a Quick ratio of 0.83. This is comparable to the rest of the industry: IX outperforms 46.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.83
IX Yearly Current Assets VS Current LiabilitesIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500B 1T 1.5T 2T 2.5T

3

3. Growth

3.1 Past

The earnings per share for IX have decreased strongly by -10.80% in the last year.
Measured over the past years, IX shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.09% on average per year.
The Revenue has been growing slightly by 3.16% in the past year.
IX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.43% yearly.
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%25.45%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%10.73%

3.2 Future

Based on estimates for the next years, IX will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.58% on average per year.
IX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.00% yearly.
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y19.91%
EPS Next 5Y14.58%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y7.17%
Revenue Next 5Y6%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IX Yearly Revenue VS EstimatesIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1T 2T 3T
IX Yearly EPS VS EstimatesIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100 200 300 400

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.96, IX is valued correctly.
IX's Price/Earnings is on the same level as the industry average.
IX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.17.
A Price/Forward Earnings ratio of 13.39 indicates a correct valuation of IX.
IX's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of IX to the average of the S&P500 Index (23.79), we can say IX is valued slightly cheaper.
Industry RankSector Rank
PE 13.96
Fwd PE 13.39
IX Price Earnings VS Forward Price EarningsIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

IX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IX is cheaper than 66.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.22
IX Per share dataIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

IX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IX's earnings are expected to grow with 19.91% in the coming years.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y21.71%
EPS Next 3Y19.91%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.37%, IX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.35, IX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.94, IX pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.37%

5.2 History

The dividend of IX is nicely growing with an annual growth rate of 7.63%!
IX has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of IX decreased in the last 3 years.
Dividend Growth(5Y)7.63%
Div Incr Years2
Div Non Decr Years2
IX Yearly Dividends per shareIX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

5.3 Sustainability

IX pays out 38.56% of its income as dividend. This is a sustainable payout ratio.
IX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.56%
EPS Next 2Y21.71%
EPS Next 3Y19.91%
IX Yearly Income VS Free CF VS DividendIX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200B -200B -400B
IX Dividend Payout.IX Dividend Payout, showing the Payout Ratio.IX Dividend Payout.PayoutRetained Earnings

ORIX - SPONSORED ADR

NYSE:IX (1/7/2026, 5:25:49 PM)

After market: 29.88 0 (0%)

29.88

-0.19 (-0.63%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-06 2025-11-06
Earnings (Next)02-09 2026-02-09
Inst Owners49.67%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap33.27B
Revenue(TTM)2.94T
Net Income(TTM)351.60B
Analysts77.33
Price Target29.8 (-0.27%)
Short Float %0.04%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield 3.37%
Yearly Dividend0.77
Dividend Growth(5Y)7.63%
DP38.56%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.62%
Min EPS beat(2)-26.43%
Max EPS beat(2)-6.82%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.83%
Min Revenue beat(2)-9.12%
Max Revenue beat(2)-8.55%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.97%
PT rev (3m)2.86%
EPS NQ rev (1m)0.59%
EPS NQ rev (3m)0.59%
EPS NY rev (1m)1.2%
EPS NY rev (3m)9.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)1.43%
Valuation
Industry RankSector Rank
PE 13.96
Fwd PE 13.39
P/S 1.81
P/FCF N/A
P/OCF 4.01
P/B 1.27
P/tB 1.77
EV/EBITDA 10.22
EPS(TTM)2.14
EY7.16%
EPS(NY)2.23
Fwd EY7.47%
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)7.45
OCFY24.94%
SpS16.48
BVpS23.44
TBVpS16.87
PEG (NY)0.55
PEG (5Y)N/A
Graham Number33.6
Profitability
Industry RankSector Rank
ROA 2.08%
ROE 8.6%
ROCE 3.7%
ROIC 2.59%
ROICexc 2.83%
ROICexgc 3.72%
OM 19%
PM (TTM) 12.23%
GM 42.41%
FCFM N/A
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
ROICexc(3y)2.88%
ROICexc(5y)2.73%
ROICexgc(3y)3.79%
ROICexgc(5y)3.66%
ROCE(3y)3.76%
ROCE(5y)3.56%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y0.16%
ROICexc growth 3Y1.76%
ROICexc growth 5Y0.31%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
F-Score6
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Debt/EBITDA 6.65
Cap/Depr 339.82%
Cap/Sales 47.23%
Interest Coverage 250
Cash Conversion 137.5%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.83
Altman-Z 0.79
F-Score6
WACC3.68%
ROIC/WACC0.7
Cap/Depr(3y)325.04%
Cap/Depr(5y)298.28%
Cap/Sales(3y)43.48%
Cap/Sales(5y)39.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%25.45%
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y19.91%
EPS Next 5Y14.58%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%10.73%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y7.17%
Revenue Next 5Y6%
EBIT growth 1Y-4.51%
EBIT growth 3Y7.89%
EBIT growth 5Y6.16%
EBIT Next Year12561.8%
EBIT Next 3Y451.15%
EBIT Next 5YN/A
FCF growth 1Y-235.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.57%
OCF growth 3Y5.62%
OCF growth 5Y4.52%

ORIX - SPONSORED ADR / IX FAQ

What is the ChartMill fundamental rating of ORIX - SPONSORED ADR (IX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IX.


Can you provide the valuation status for ORIX - SPONSORED ADR?

ChartMill assigns a valuation rating of 4 / 10 to ORIX - SPONSORED ADR (IX). This can be considered as Fairly Valued.


Can you provide the profitability details for ORIX - SPONSORED ADR?

ORIX - SPONSORED ADR (IX) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for IX stock?

The Price/Earnings (PE) ratio for ORIX - SPONSORED ADR (IX) is 13.96 and the Price/Book (PB) ratio is 1.27.


How sustainable is the dividend of ORIX - SPONSORED ADR (IX) stock?

The dividend rating of ORIX - SPONSORED ADR (IX) is 7 / 10 and the dividend payout ratio is 38.56%.